Blood Sample Collection in Geriatric Patients

November 20, 2023 updated by: Tulay Basak, Saglik Bilimleri Universitesi

The Effect of Duration of Pressure Applied After Blood Sample Collection on the Development of Ecchymosis in Geriatric Patients Using Oral and Subcutaneous Anticoagulants: A Randomized Controlled Trial

This study aimed to evaluate the effect of different durations of a specific pressure applied after blood collection on the development of ecchymosis in geriatric patients using oral and subcutaneous anticoagulants.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The research sample consisted of patients hospitalized in the Geriatrics Clinic of a city hospital. This study aimed to evaluate the effect of different durations of a specific pressure applied after blood collection on the development of ecchymosis in geriatric patients using oral and subcutaneous anticoagulants. In this study, whether ecchymosis developed at the 24th, 48th and 72nd hours after the blood collection procedure was evaluated.

Study Type

Interventional

Enrollment (Actual)

164

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Ankara, Turkey, 06010
        • Tulay Basak

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

61 years and older (Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • patients aged 65 years and over
  • who voluntarily agreed to participate in the study
  • who used oral (Rivaroxaban 10-15-20 mg, Dabigatran, 75-110-150 mg, Apixaban 2.5-5 mg) and subcutaneous (Enoxaparin sodium 6000-4000 anti-Xa IU/0.6-0.4 ml) anticoagulants
  • who were literate in Turkish
  • who were scheduled for blood collection
  • who would undergo blood collection from the antecubital site with vacutainer

Exclusion Criteria:

  • patients with communication problems
  • patients with hematoma, ecchymosis, and scarring in the antecubital site
  • patients who would be discharged before 72 hours
  • patients with coagulation disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control group
Routine procedure
Experimental: Group A
1 min pressure applied
Other: 20 N pressure for 1 minute
After blood collection, 20 N pressure applied for 1 minute
Experimental: Group B
3 min pressure applied
Other: 20 N pressure for 3 minute
After blood collection, 20 N pressure applied for 3 minute
Experimental: Group C
5 min pressure applied
Other: 20 N pressure for 5 minute
After blood collection, 20 N pressure applied for 5 minute

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
number of participants with ecchymosis developed.
Time Frame: at the 24 th hours
In this study, whether ecchymosis developed at the 24th, 48th, and 72nd hours after the blood collection procedure was evaluated.
at the 24 th hours
number of participants with ecchymosis developed.
Time Frame: at the 48 th hours
In this study, whether ecchymosis developed at the 24th, 48th, and 72nd hours after the blood collection procedure was evaluated.
at the 48 th hours
number of participants with ecchymosis developed.
Time Frame: at the 72 nd hours
In this study, whether ecchymosis developed at the 24th, 48th, and 72nd hours after the blood collection procedure was evaluated.
at the 72 nd hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Saglik Bilimleri Universitesi

Investigators

  • Principal Investigator: Tulay Basak, Saglik Bilimleri Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 30, 2021

Primary Completion (Actual)

June 15, 2022

Study Completion (Actual)

June 15, 2022

Study Registration Dates

First Submitted

October 7, 2022

First Submitted That Met QC Criteria

October 12, 2022

First Posted (Actual)

October 14, 2022

Study Record Updates

Last Update Posted (Estimated)

November 21, 2023

Last Update Submitted That Met QC Criteria

November 20, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 779

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Venipuncture Site Bruise

Clinical Trials on 20 N pressure for 1 minute

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe